Ti Shen
About
In The Last Decade
Ti Shen
52 papers receiving 521 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 135
- Neurology 120
- Hematology 119
- Pathology and Forensic Medicine 118
- Nutrition and Dietetics 81
Countries citing papers authored by Ti Shen
This map shows the geographic impact of Ti Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ti Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ti Shen more than expected).
Fields of papers citing papers by Ti Shen
This network shows the impact of papers produced by Ti Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ti Shen. The network helps show where Ti Shen may publish in the future.
Co-authorship network of co-authors of Ti Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Ti Shen. A scholar is included among the top collaborators of Ti Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ti Shen. Ti Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 18 | |
| 3 | Good outcome of severe lupus patients with high-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation: a 10-year follow-up study. | 17 |
| 4 | 12 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | [An analysis of disease spectrum of patients admitted to the General Internal Medicine Unit at Peking Union Medical College Hospital from 2004 to 2008, and the value of general internal medicine unit in comprehensive hospitals]. | 1 |
| 8 | 105 | |
| 9 | 6 | |
| 10 | 26 | |
| 11 | 16 | |
| 12 | 24 | |
| 13 | 3 | |
| 14 | 14 | |
| 15 | 6 | |
| 16 | 14 | |
| 17 | A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation. | 7 |
| 18 | [Gene polymorphisms of rennin-angiotensin system and coronary artery thrombosis disease]. | 9 |
| 19 | 42 | |
| 20 | Clinical applications of hematopoietic growth factors | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.